Manning & Napier Group, LLC Biomarin Pharmaceutical Inc Transaction History

Manning & Napier Group, LLC

$8.76 Billion
Q1 2024

A detailed history of Manning & Napier Group, LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Manning & Napier Group, LLC holds 1,153,785 shares of BMRN stock, worth $76.9 Million. This represents 1.15% of its overall portfolio holdings.

Number of Shares

1,153,785

Previous 1,145,113 0.76%

Holding current value

$76.9 Million

Previous $110 Million 8.73%

% of portfolio

1.15%

Previous 1.32%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 15, 2024	BUY	$83.81 - $99.0 $726,800 - $858,528	8,672 Added 0.76%	1,153,785 $101 Million
Q4 2023 Jan 19, 2024	BUY	$76.22 - $98.51 $469,591 - $606,920	6,161 Added 0.54%	1,145,113 $110 Million
Q3 2023 Oct 20, 2023	BUY	$85.07 - $94.48 $101,488 - $112,714	1,193 Added 0.1%	1,138,952 $101 Million
Q2 2023 Jul 26, 2023	BUY	$86.68 - $100.3 $3.21 Million - $3.72 Million	37,041 Added 3.37%	1,137,759 $98.6 Million
Q1 2023 Apr 17, 2023	BUY	$87.74 - $117.27 $19.8 Million - $26.5 Million	226,152 Added 25.86%	1,100,718 $107 Million
Q4 2022 Jan 26, 2023	SELL	$80.93 - $108.63 $4.63 Million - $6.22 Million	-57,225 Reduced 6.14%	874,566 $0
Q3 2022 Oct 18, 2022	SELL	$82.16 - $96.94 $1.2 Million - $1.42 Million	-14,610 Reduced 1.54%	931,791 $79 Million
Q2 2022 Jul 12, 2022	SELL	$71.48 - $86.85 $54.3 Million - $65.9 Million	-758,954 Reduced 44.5%	946,401 $78.4 Million
Q1 2022 Apr 19, 2022	SELL	$74.28 - $92.69 $2.35 Million - $2.94 Million	-31,704 Reduced 1.83%	1,705,355 $131 Million
Q4 2021 Jan 27, 2022	SELL	$71.72 - $91.47 $424,725 - $541,685	-5,922 Reduced 0.34%	1,737,059 $153 Million
Q3 2021 Oct 14, 2021	BUY	$74.77 - $85.47 $1.17 Million - $1.33 Million	15,597 Added 0.9%	1,742,981 $135 Million
Q2 2021 Jul 19, 2021	BUY	$75.51 - $84.79 $1.7 Million - $1.91 Million	22,542 Added 1.32%	1,727,384 $144 Million
Q1 2021 Apr 28, 2021	BUY	$74.73 - $90.69 $46.4 Million - $56.4 Million	621,482 Added 57.37%	1,704,842 $129 Million
Q4 2020 Jan 20, 2021	SELL	$72.61 - $90.2 $3.58 Million - $4.45 Million	-49,358 Reduced 4.36%	1,083,360 $95 Million
Q3 2020 Oct 29, 2020	BUY	$71.87 - $131.03 $11.7 Million - $21.3 Million	162,195 Added 16.71%	1,132,718 $86.2 Million
Q2 2020 Jul 10, 2020	SELL	$79.55 - $124.22 $6.35 Million - $9.92 Million	-79,835 Reduced 7.6%	970,523 $120 Million
Q1 2020 Apr 13, 2020	SELL	$71.37 - $96.85 $3.56 Million - $4.83 Million	-49,833 Reduced 4.53%	1,050,358 $88.8 Million
Q4 2019 Jan 10, 2020	BUY	$64.27 - $86.37 $23.8 Million - $32 Million	370,098 Added 50.69%	1,100,191 $93 Million
Q3 2019 Oct 10, 2019	BUY	$67.4 - $85.11 $271,756 - $343,163	4,032 Added 0.56%	730,093 $49.2 Million
Q2 2019 Jul 24, 2019	SELL	$80.35 - $93.9 $14.9 Million - $17.4 Million	-184,898 Reduced 20.3%	726,061 $62.2 Million
Q1 2019 Apr 10, 2019	SELL	$84.2 - $98.62 $7.49 Million - $8.77 Million	-88,959 Reduced 8.9%	910,959 $80.9 Million
Q4 2018 Jan 24, 2019	SELL	$80.14 - $106.07 $32.4 Million - $42.9 Million	-404,610 Reduced 28.81%	999,918 $85.1 Million
Q3 2018 Oct 10, 2018	SELL	$93.92 - $105.72 $45 Million - $50.7 Million	-479,145 Reduced 25.44%	1,404,528 $136 Million
Q2 2018 Jul 13, 2018	SELL	$76.01 - $99.03 $2.49 Million - $3.25 Million	-32,785 Reduced 1.71%	1,883,673 $177 Million
Q1 2018 May 01, 2018	SELL	$77.67 - $92.63 $5 Million - $5.97 Million	-64,419 Reduced 3.25%	1,916,458 $155 Million
Q4 2017 Feb 05, 2018	BUY	$80.76 - $95.13 $160 Million - $188 Million	1,980,877	1,980,877 $177 Million

Others Institutions Holding BMRN

# of Institutions

637

Shares Held

177M

Call Options Held

2.01M

Put Options Held

1.28M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.4B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Manning & Napier Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Manning & Napier Group, LLC with notifications on news.

Account

Manning & Napier Group, LLC Biomarin Pharmaceutical Inc Transaction History